Critical Path Ventures
5 rounds tracked since 3 July 2025.
- Rounds
- 5
- Led
- 3
- Capital in these rounds
- $86.2M
Sectors
Countries
Rounds
- SonoMindLeadLow-intensity focused ultrasound therapy for treatment-resistant depression $23.5MSeries A · 12 May
- Alkion BioInnovationsPlant cell bioproduction of QS-21 saponin adjuvants for vaccines $5.1MSeries A · 26 Nov
- RDSConnected patch for remote patient monitoring (MultiSense) $16.4MSeries A · 29 Sept
- SonomindLeadNon-invasive ultrasound neuromodulation device for treatment-resistant depression $2.4MSeed · 24 Sept
- BrainEverLeadDevelops neuronal reprogramming therapies for ALS and neurodegenerative diseases $38.9MSeries B · 3 Jul
No round matches these filters.